Inactive Instrument

News Verona Pharma Plc London S.E.

Equities

GB00B06GSH43

End-of-day quote London S.E. Other stock markets
- ^GBX	-

Apr. 16	European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	MT
Apr. 16	Piper Sandler Raises Verona Pharma's Price Target to $36 From $31, Keeps Overweight Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	Apr. 16	MT
Piper Sandler Raises Verona Pharma's Price Target to $36 From $31, Keeps Overweight Rating	Apr. 16	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	Apr. 04	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	Mar. 25	MT
Verona Pharma : Notice and Proxy Statement AGM 2024	Mar. 21	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	Mar. 21	PU
Verona Pharma : Notice and Proxy Statement AGM 2024	Mar. 19	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	Mar. 19	PU
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	Mar. 14	MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	Mar. 13	MT
Andrew Fisher Joins Verona Pharma as General Counsel	Mar. 04	AQ
Verona Pharma plc Announces Management Changes	Mar. 04	CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	Mar. 01	MT
Verona Pharma Shares Rise After Narrower-Than-Expected Q4 Loss	Feb. 29	MT
Verona Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Transcript : Verona Pharma plc, Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Feb. 29	AQ
Verona Pharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Verona Pharma Plc London S.E.

Equities

GB00B06GSH43

Summary

Filters